Polakova Veronika, Matulova Jana, Brtnikova Jana, Fohlerova Zdenka, Smerkova Kristyna, Kaiser Jozef, Zikmund Tomas, Prochazkova Petra, Zidek Jan, Vojtova Lucy
Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.
Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Zemedelska 1, 613 00 Brno, Czech Republic.
ACS Omega. 2025 Jul 28;10(35):39799-39813. doi: 10.1021/acsomega.5c03661. eCollection 2025 Sep 9.
The treatment of chronic wounds remains a major challenge in regenerative medicine due to prolonged healing times, susceptibility to infection, and underlying conditions like diabetes. Incorporating bioactive and antibacterial nanoparticles (NPs) into wound dressings can significantly enhance their mechanical properties, structural integrity, and functionality, improving stability, biocompatibility, and healing efficacy. However, conventional methods of loading NPs in polymer matrices often lead to uneven distribution and localized toxicity. To overcome these limitations, we employ a novel synthesis of copper nanoparticles (CuNPs) using an encapsulation method via the self-assembled polymerization of dopamine (DOPA) or tannic acid (TA) within collagen/carboxymethyl cellulose (Coll/CMC) 3D freeze-dried scaffolds. When CuNPs are synthesized , both DOPA and TA act as reducing and encapsulating agents. However, synthesis within Coll/CMC scaffolds results in TA functioning solely as a reducing agent, while DOPA serves both as a reducing agent and, through its polymerization into polydopamine, as a stabilizing agent. The polydopamine network enhances collagen fiber adhesion to CuNPs and stabilizes them via noncovalent interactions. Notably, the DOPA-/Cu sample exhibited prolonged enzymatic stability for up to 7 days. X-ray microcomputed tomography confirmed the homogeneous distribution of CuNPs throughout the scaffold. Biological assays demonstrated the enhanced antibacterial efficacy of DOPA/TA-/Cu samples against and MRSA, along with cytocompatibility with 3T3 fibroblasts. Future research should explore the application of these scaffolds and their potential in regenerative medicine for treating infected wounds.
由于愈合时间长、易感染以及糖尿病等潜在病症,慢性伤口的治疗仍然是再生医学中的一项重大挑战。将生物活性和抗菌纳米颗粒(NPs)纳入伤口敷料可以显著增强其机械性能、结构完整性和功能,提高稳定性、生物相容性和愈合效果。然而,在聚合物基质中负载纳米颗粒的传统方法往往会导致分布不均和局部毒性。为了克服这些限制,我们采用一种新颖的方法合成铜纳米颗粒(CuNPs),即通过多巴胺(DOPA)或单宁酸(TA)在胶原蛋白/羧甲基纤维素(Coll/CMC)三维冷冻干燥支架内的自组装聚合进行包封。合成CuNPs时,DOPA和TA都充当还原剂和包封剂。然而,在Coll/CMC支架内合成时,TA仅作为还原剂起作用,而DOPA既作为还原剂,又通过聚合成聚多巴胺作为稳定剂。聚多巴胺网络增强了胶原纤维与CuNPs的粘附,并通过非共价相互作用使其稳定。值得注意的是,DOPA-/Cu样品表现出长达7天的延长酶稳定性。X射线微计算机断层扫描证实了CuNPs在整个支架中的均匀分布。生物学测定表明,DOPA/TA-/Cu样品对大肠杆菌和耐甲氧西林金黄色葡萄球菌(MRSA)具有增强的抗菌效果,并且与3T3成纤维细胞具有细胞相容性。未来的研究应探索这些支架的应用及其在再生医学中治疗感染伤口的潜力。